We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.87%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$21.4M
(-10%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-25.37%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
217
New
29
Increased
61
Reduced
33
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$5.09M |
| 2 |
GSI Technology
GSIT
|
+$2.17M |
| 3 |
Annovis Bio
ANVS
|
+$1.48M |
| 4 |
Clene
CLNN
|
+$1.45M |
| 5 |
Karyopharm Therapeutics
KPTI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$4.21M |
| 2 |
Silicom
SILC
|
+$2.81M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.59M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$2.17M |
| 5 |
Carvana
CVNA
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.84% |
| 2 | Healthcare | 16.62% |
| 3 | Financials | 6.45% |
| 4 | Real Estate | 2.82% |
| 5 | Consumer Staples | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
American Homes 4 Rent
AMH
$12B
| $234K | 0.13% |
+6,598
| New | +$224K |
|
77
Syndax Pharmaceuticals
SNDX
$1.69B
| $228K | 0.12% |
+10,900
| New | +$227K |
|
|
JBGS
78
JBG SMITH
JBGS
$818M
| $215K | 0.12% |
14,300
| – | – |
|
|
DEA
79
Easterly Government Properties
DEA
$1.13B
| $207K | 0.11% |
5,720
| – | – |
|
|
VRE
80
DELISTED
Veris Residential
VRE
| $188K | 0.1% |
11,733
-7,155
| -38% | -$116K |
|
81
Zeta Global
ZETA
$5.38B
| $188K | 0.1% |
22,000
+4,000
| +22% | +$36.6K |
|
|
MRNS
82
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $186K | 0.1% |
+44,200
| New | +$379K |
|
|
TFFP
83
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $183K | 0.1% |
15,564
-1,549
| -9% | -$22.3K |
|
|
CGRN
84
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $181K | 0.1% |
150,754
-150
| -0.1% | -$184 |
|
85
Asure Software
ASUR
$232M
| $174K | 0.09% |
14,300
+3,000
| +27% | +$40K |
|
86
PUT
AstraZeneca
AZN
$263B
| $166K | 0.09% |
68,600
+55,800
| +436% | +$8.21M |
|
87
Ribbon Communications
RBBN
$377M
| $164K | 0.09% |
58,671
+13,671
| +30% | +$37.9K |
|
|
NOTE
88
DELISTED
FiscalNote
NOTE
| $163K | 0.09% |
3,723
+965
| +35% | +$27.1K |
|
|
AMRS
89
PUT
DELISTED
Amyris Inc.
AMRS
| $159K | 0.09% |
333,100
+162,200
| +95% | +$151K |
|
|
RVLP
90
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $156K | 0.09% |
278,654
-44,175
| -14% | -$39K |
|
91
Applied Digital
APLD
$7.89B
| $149K | 0.08% |
+15,936
| New | +$95K |
|
92
Evolv Technologies
EVLV
$995M
| $148K | 0.08% |
+24,588
| New | +$116K |
|
|
SQNS
93
Sequans Communications SA
SQNS
$36.4M
| $146K | 0.08% |
2,611
+339
| +15% | +$19.3K |
|
|
ITOS
94
DELISTED
iTeos Therapeutics
ITOS
| $144K | 0.08% |
+10,900
| New | +$155K |
|
95
Ceragon Networks
CRNT
$197M
| $137K | 0.07% |
65,397
+26,397
| +68% | +$48.7K |
|
96
Lantronix
LTRX
$240M
| $136K | 0.07% |
32,378
+10,766
| +50% | +$45.9K |
|
97
CALL
Arcus Biosciences
RCUS
$3.55B
| $133K | 0.07% |
67,300
+41,500
| +161% | +$790K |
|
98
Tempest Therapeutics
TPST
$13.7M
| $129K | 0.07% |
+7,812
| New | +$197K |
|
|
NTST
99
NETSTREIT Corp
NTST
$2.09B
| $129K | 0.07% |
7,211
-18,091
| -72% | -$325K |
|
|
CTLP
100
DELISTED
Cantaloupe
CTLP
| $127K | 0.07% |
15,978
+2,478
| +18% | +$16.1K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Worth Venture Partners held 217 positions worth $184M, down 10% from $205M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $46.6M in Q2 2023, closing 50 positions and reducing 33 holdings. Its most notable exit was Adtran, an estimated $4.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in GSI Technology worth $2.76M.
- Worth Venture Partners's largest Q2 2023 buy was GSI Technology: 499,400 shares worth $2.76M.
- Worth Venture Partners added most to Microchip Technology in Q2 2023, an estimated $5.09M increase.
- Worth Venture Partners's biggest Q2 2023 reduction was Marinus Pharmaceuticals, Inc, cutting an estimated $2.59M.
- Worth Venture Partners fully exited Adtran in Q2 2023, selling an estimated $4.21M.
- Worth Venture Partners's ten largest holdings make up 36% of its $184M portfolio in Q2 2023.
- Worth Venture Partners opened 29 new positions and closed 50 in Q2 2023.
- Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $184M.
Based on Worth Venture Partners's 13F filing for Q2 2023, filed 14 Aug 2023.